# Hydralazine Hydrochloride

NDC: 68475-514
Generic name: Hydralazine Hydrochloride
Labeler / Manufacturer: Navinta LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20251125

FDA application: ANDA202938

## Active ingredients

- HYDRALAZINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68475-514"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68475-514
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae5d85df-11a3-4952-ade2-596d57cdd987